Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Low T Drug Lawsuits Centralized as One MDL in Illinois Federal Court June 6, 2014 Austin Kirk Add Your Comments A panel of federal judges has ordered all product liability lawsuits filed in U.S. District Courts nationwide involving injuries associated with the use of any testosterone replacement therapy (TRT) will be centralized before one judge in the Northern District of Illinois as part of an MDL, or multidistrict litigation. Following oral arguments late last month, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an order (PDF) today, which transfers cases involving any “Low T” drugs to U.S. District Judge Matthew F. Kennelly for coordinated handling during pretrial proceedings. The ruling affects at least 45 lawsuits filed against the makers of AndroGel, Axiron, Testim, Foresta, AndroDerm and Depo-Testosterone. However, any future cases filed involving any testosterone gel, cream, injectiom or other prescription treatment will also be transferred to the MDL. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Since all of the low T drug lawsuits involve common allegations that the medications caused plaintiffs suffer heart attacks, strokes, blood clots and other cardiovascular injuries, the Panel decided to centralize the entire litigation to reduce the risk of duplicative discovery, avoid conflicting rulings from different judges and to serve the convenience of the parties, witnesses and the courts. Industry-Wide Consolidation While most of the complaints filed so far have involved problems associated with the use of AndroGel, which is the most widely used testosterone treatment, a number of the lawsuits have been filed against the makers of competing low T drugs, including Axiron, Testim, AndroDerm, Depo-Testosterone and others. The panel of judges heard various proposals regarding how the mounting lawsuits over low T drugs should be managed during a hearing on May 29.While some plaintiffs and many of the defendants called for all of the testosterone cases to be centralized as part of one proceeding, other proposals called for only AndroGel lawsuits or cases involving testosterone gels to be included in the MDL. “We are typically hesitant to centralize litigation on an industry-wide basis,” the panel of federal judges wrote in the order issued June 6. “In these circumstances, however, we think it is the best solution. Plaintiffs suggest that related cases will number in the thousands. Significantly, in the actions and potential tag-along actions already filed, a number of plaintiffs used more than one testosterone replacement therapy.” The Panel noted that all of the lawsuits involve common factual questions regarding general causation and the background science regarding the role of testosterone in the aging body. Common regulatory issues will also impact all of the different medications, according to the Panel, as most of the lawsuits have been filed in the wake of an FDA announcement issued on January 31, which indicated that the agency was reviewing the risk of stroke, heart attack and death among men taking any FDA-approved testosterone drugs. The FDA investigation was launched following several studies published in recent months involving the link between low T drugs and heart attacks. In November 2013, a study published in the Journal of the American Medical Association suggested side effects of testosterone may increase the risk of heart attacks, strokes, and death among older men with certain pre-existing heart problems. This research was followed by a study published by the medical journal PLOSOne in January 2014, which found that low testosterone treatments may double the risk of heart attack for younger men with heart disease and men over the age of 65, regardless of their prior heart conditions. As product liability lawyers continue to review and file new cases over the coming months and years, it is ultimately expected that several thousand cases will be included in the Low T drug litigation. Tags: Abbott Laboratories, AbbVie, Androderm, AndroGel, Axiron, Depo-Testosterone, Heart Attack, Illinois, Stroke, Testim, Testosterone, Testosterone Gel Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)